Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
Open Access
- 28 December 2019
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 10 (1), 51
- https://doi.org/10.3390/biom10010051
Abstract
Most malignant tumors originate from epithelial tissues in which tight junctions mediate cell–cell interactions. Tight junction proteins, especially claudin-3 (CLDN3), are overexpressed in various cancers. Claudin-3 is exposed externally during tumorigenesis making it a potential biomarker and therapeutic target. However, the development of antibodies against specific CLDN proteins is difficult, because CLDNs are four-transmembrane domain proteins with high homology among CLDN family members and species. Here, we developed a human IgG1 monoclonal antibody (h4G3) against CLDN3 through scFv phage display using CLDN3-overexpressing stable cells and CLDN3-embedded lipoparticles as antigens. The h4G3 recognized the native conformation of human and mouse CLDN3 without cross-reactivity to other CLDNs. The binding kinetics of h4G3 demonstrated a sub-nanomolar affinity for CLDN3 expressed on the cell surface. The h4G3 showed antibody-dependent cellular cytotoxicity (ADCC) according to CLDN3 expression levels in various cancer cells by the activation of FcγRIIIa (CD16a). The biodistribution of h4G3 was analyzed by intravenous injection of fluorescence-conjugated h4G3 which showed that it localized to the tumor site in xenograft mice bearing CLDN3-expressing tumors. These results indicate that h4G3 recognizes CLDN3 specifically, suggesting its value for cancer diagnosis, antibody-drug conjugates, and potentially as a chimeric antigen receptor (CAR) for CLDN3-expressing pan-carcinoma.This publication has 80 references indexed in Scilit:
- C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and CarboplatinClinical Cancer Research, 2011
- Predicted expansion of the claudin multigene familyFEBS Letters, 2011
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Claudin Family of Proteins and Cancer: An OverviewJournal of Oncology, 2010
- Cyclin A/cdk2 Regulates Adenomatous Polyposis Coli-dependent Mitotic Spindle AnchoringOnline Journal of Public Health Informatics, 2009
- Molecular Determinants of the Interaction between Clostridium perfringens Enterotoxin Fragments and Claudin-3Online Journal of Public Health Informatics, 2009
- Affinity and Avidity in Antibody-Based Tumor TargetingCancer Biotherapy & Radiopharmaceuticals, 2009
- Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon ResonanceOnline Journal of Public Health Informatics, 2008
- Claudin upregulation in ovarian carcinoma effusions is associated with poor survivalHuman Pathology, 2008
- Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancerGynecologic Oncology, 2008